You are here

  • Home
  • Archive
  • Volume 9, Issue 12
  • Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Original research
Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma

 

Online download statistics by month:

Online download statistics by month: December 2021 to August 2024

AbstractFullPdf
Dec 202113161360467
Jan 2022542588361
Feb 2022308338319
Mar 2022359379179
Apr 2022295309141
May 2022301323180
Jun 2022278287134
Jul 2022371377181
Aug 2022444454153
Sep 2022426435178
Oct 2022593598167
Nov 2022353359178
Dec 2022287290113
Jan 202320320598
Feb 2023309316157
Mar 2023297308150
Apr 2023323332160
May 2023373379141
Jun 2023302312147
Jul 2023283295118
Aug 2023259262108
Sep 202332833697
Oct 2023257266108
Nov 2023297299124
Dec 2023251254141
Jan 2024232234128
Feb 2024279283103
Mar 2024343348160
Apr 2024283284124
May 2024226230139
Jun 2024202204110
Jul 2024178180107
Aug 202411912089
Total11217115445260